Business Description
Center Laboratories Inc
ISIN : TW0004123005
Share Class Description:
ROCO:4123: Ordinary SharesTotal Employee Number:
182Description
Center Laboratories Inc is engaged in the manufacture and sale of various Western pharmaceuticals, including Western medicine manufacturing, wholesale, and retail. The Company operates through the following segments: Pharmaceutical Division, Biotechnology Venture Capital, and Glac Segment. The Pharmaceutical Division, which generates the majority of revenue, manufactures and sells various Western pharmaceuticals. The Biotechnology Venture Capital segment invests in domestic and foreign biotechnology undertakings, while the Glac Segment manufactures and sells probiotic products. The Company operates in Taiwan, Mainland China, and other regions, with Taiwan generating the majority of revenue.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | 0.39 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.54 | |||||
Beneish M-Score | -0.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.6 | |||||
3-Year FCF Growth Rate | 8.9 | |||||
3-Year Book Growth Rate | 8.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.59 | |||||
9-Day RSI | 42.12 | |||||
14-Day RSI | 44.31 | |||||
3-1 Month Momentum % | -6.53 | |||||
6-1 Month Momentum % | -10.79 | |||||
12-1 Month Momentum % | 4.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.35 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 130.94 | |||||
Days Sales Outstanding | 45.39 | |||||
Days Payable | 51.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.06 | |||||
Dividend Payout Ratio | 0.07 | |||||
3-Year Dividend Growth Rate | -28.8 | |||||
Forward Dividend Yield % | 2.06 | |||||
5-Year Yield-on-Cost % | 1.66 | |||||
3-Year Average Share Buyback Ratio | -2.7 | |||||
Shareholder Yield % | 7.23 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.98 | |||||
Operating Margin % | -23.88 | |||||
Net Margin % | 614.89 | |||||
EBITDA Margin % | 787.92 | |||||
FCF Margin % | -11.94 | |||||
OCF Margin % | 1.79 | |||||
ROE % | 46.8 | |||||
ROA % | 34.48 | |||||
ROIC % | -1.04 | |||||
3-Year ROIIC % | -5 | |||||
ROC (Joel Greenblatt) % | 766.64 | |||||
ROCE % | 51.63 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.3 | |||||
Shiller PE Ratio | 12.08 | |||||
Price-to-Owner-Earnings | 3.16 | |||||
PS Ratio | 20.17 | |||||
PB Ratio | 1.05 | |||||
Price-to-Tangible-Book | 1.09 | |||||
Price-to-Operating-Cash-Flow | 2500 | |||||
EV-to-EBIT | 2.73 | |||||
EV-to-EBITDA | 2.69 | |||||
EV-to-Revenue | 21.21 | |||||
EV-to-FCF | -175.55 | |||||
Price-to-GF-Value | 0.87 | |||||
Price-to-Projected-FCF | 1.92 | |||||
Price-to-Median-PS-Value | 1.1 | |||||
Earnings Yield (Greenblatt) % | 36.6 | |||||
FCF Yield % | -0.64 | |||||
Forward Rate of Return (Yacktman) % | -14.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Center Laboratories Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,516.19 | ||
| EPS (TTM) (NT$) | 11.335 | ||
| Beta | 0.2871 | ||
| 3-Year Sharpe Ratio | -0.35 | ||
| 3-Year Sortino Ratio | -0.47 | ||
| Volatility % | 22.07 | ||
| 14-Day RSI | 44.31 | ||
| 14-Day ATR (NT$) | 0.847283 | ||
| 20-Day SMA (NT$) | 38.275 | ||
| 12-1 Month Momentum % | 4.09 | ||
| 52-Week Range (NT$) | 33.1 - 51.4 | ||
| Shares Outstanding (Mil) | 758.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Center Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Center Laboratories Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.760393 Cash Dividend | 2025-10-03 | 36.64 (-1.03%) | ||
| 1.05069:1 Stock Split | 2025-10-03 | 36.64 (-1.03%) | ||
| TWD 1.361587 Cash Dividend | 2024-08-02 | 47.87 (-0.40%) | ||
| 1.1016:1 Stock Split | 2023-09-08 | 44.49 (-0.19%) | ||
| 1.14597:1 Stock Split | 2022-09-08 | 45.69 (-0.33%) | ||
| 1.09972:1 Stock Split | 2021-09-13 | 49.09 (-0.42%) | ||
| 1.04755:1 Stock Split | 2020-08-06 | 50.78 (+1.31%) | ||
| 1.14994:1 Stock Split | 2019-08-16 | 43.99 (+1.71%) | ||
| 1.04829:1 Stock Split | 2018-08-09 | 47.83 (-8.04%) | ||
| 1.1:1 Stock Split | 2017-09-07 | 27.14 (-6.14%) |
Show
Entries
Center Laboratories Inc Frequently Asked Questions
What is Center Laboratories Inc(ROCO:4123)'s stock price today?
The current price of ROCO:4123 is NT$37.50. The 52 week high of ROCO:4123 is NT$51.40 and 52 week low is NT$33.10.
When is next earnings date of Center Laboratories Inc(ROCO:4123)?
The next earnings date of Center Laboratories Inc(ROCO:4123) is .
Does Center Laboratories Inc(ROCO:4123) pay dividends? If so, how much?
The Dividend Yield %  of Center Laboratories Inc(ROCO:4123) is 2.06% (As of Today), Highest Dividend Payout Ratio of Center Laboratories Inc(ROCO:4123) was 1.96. The lowest was 0.07. And the median was 0.17. The  Forward Dividend Yield % of Center Laboratories Inc(ROCO:4123) is 2.06%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Center Laboratories Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers